Poulin C, Alary M, Massé R
Centre de santé publique de Québec, Quebec.
Can J Public Health. 1997 Nov-Dec;88(6):397-400. doi: 10.1007/BF03403914.
This study aimed to determine the number and characteristics of the blood recipients tested for HIV infection as a result of the provincial HIV antibody screening program (directed to persons transfused between 1978 and 1985 and their contacts) and to estimate the rate of HIV seroprevalence among them. All physicians in the province of Quebec were provided with a special prescription form for HIV testing of eligible patients. Over a six-month period, a total of 6,348 special prescription forms were used. The HIV seroprevalence was 0.13% (95% confidence interval: 0.04% to 0.2%). We estimated an increase of 16.5% (12,061 tests) in the number of HIV tests related to the program. These results were consistent with those found by similar programs elsewhere in Canada but less than expected. Multiple strategies, including direct notification of transfusion recipients, particularly pediatric patients, are probably necessary to reach infected blood recipients still unaware of their infection.
本研究旨在确定因省级艾滋病毒抗体筛查项目(针对1978年至1985年间接受输血者及其接触者)而接受艾滋病毒感染检测的受血者数量和特征,并估计他们中的艾滋病毒血清流行率。魁北克省的所有医生都收到了一份用于对符合条件的患者进行艾滋病毒检测的特殊处方表格。在六个月的时间里,总共使用了6348份特殊处方表格。艾滋病毒血清流行率为0.13%(95%置信区间:0.04%至0.2%)。我们估计与该项目相关的艾滋病毒检测数量增加了16.5%(12061次检测)。这些结果与加拿大其他地方类似项目的结果一致,但低于预期。可能需要多种策略,包括直接通知输血受血者,尤其是儿科患者,以找到仍未意识到自己感染的受感染血液接受者。